Gallman Cari bought BMY
March 10, 2024 · Form 4 insider transaction
Gallman Cari bought 11,029 shares of Bristol-Myers Squibb Company at $0.00 per share, a transaction worth N/A. The trade was recorded as grant or award and disclosed on an SEC Form 4, filed 2 days after the transaction.
Direction
Acquired (buy-side)
Shares
11,029
Price
$0.00
Total value
N/A
InsiderGallman Cari
Role—
SecurityPerformance Shares
Transaction codeA: Grant or award
Transaction dateMarch 10, 2024
Filing dateMarch 12, 2024
Shares owned after11,029
OwnershipDirect
10b5-1 planNo
AmendedNo
Footnotes
Each performance share converts into one share of common stock upon distribution in the first quarter of 2027.